Long-term immunogenicity of hepatitis a virus vaccine in alaska 17 years after initial childhood series

Journal of Infectious Diseases

Volumn 207, Issue 3, 2013, Pages 493-496

  Raczniak, Gregory A ^a,c   Bulkow, Lisa R ^a   Bruce, Michael G ^a   Zanis, Carolyn L ^a   Baum, Richard L ^a   Snowball, Mary M ^b   Byrd, Kathy K ^d   Sharapov, Umid M ^d   Hennessy, Thomas W ^a   McMahon, Brian J ^a,b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Alaska Native Tribal Health Consortium   (United States)

^c CDC   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

enterovirus infections; hepatitis A; immunogenicity; inactivated hepatitis A vaccine; infectious hepatitis

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHILD; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FOLLOW UP; GEOMETRIC MEAN CONCENTRATION; HEPATITIS A; HUMAN; IMMUNOGENICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; VACCINATION; VACCINATION SCHEDULE; CLINICAL EFFECTIVENESS; DOSAGE SCHEDULE COMPARISON; DRUG RESPONSE; FEMALE; HEPATITIS A VIRUS; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ALASKA; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS; HUMANS; YOUNG ADULT;

EID: 84872025437     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis710     Document Type: Article

References (14)

1. Bulkow LR, Wainwright RB, McMahon BJ, Middaugh JP, Jenkerson SA, Margolis HS. Secular trends in hepatitis A virus infection among Alaska Natives. J Infect Dis 1993; 168:1017-20.
2. Peach D, McMahon BJ, Bulkow L, Funk E, Harpaz R, Margolis HS. Impact of recurrent epidemics of hepatitis a virus infection on population immunity levels: Bristol Bay, Alaska. J Infect Dis 2002; 186: 1081-5.
3. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996; 150:733-9.
4. Hammitt LL, Bulkow L, Hennessy TW, et al. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 2008; 198:1776-82.
5. Byrd KK, Bruden DL, Bruce MG, et al. Long-term immunogenicity of inactivated hepatitis A vaccine: Follow-up at 15 years. J Pediatr Infect Dis 2010; 5:321-7.
6. Dorell CG, Yankey D, Byrd KK, Murphy TV. Hepatitis a vaccination coverage among adolescents in the United States. Pediatrics 2012; 129:213-21.
7. Byrd KK, Redd JT, Holman RC, Haberling DL, Cheek JE. Changing trends in viral hepatitis-associated hospitalizations in the American Indian/Alaska Native population, 1995-2007. Public Health Rep 2011; 126:816-25.
8. McLaughlin J, Castordale L. 2010 annual (January-December) infectious disease report. Alaska Epidemiol Bull 2011; 7. http://www. epi. alaska. gov/bulletins/docs/b2011-07. pdf. Accessed 3 December 2012.
9. Singleton RJ, Hess S, Bulkow LR, Castrodale L, Provo G, McMahon BJ. Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska. Vaccine 2010; 28: 6298-304.
10. Van Herck K, Jacquet JM, Van Damme P. Antibody persistence and immune memory in healthy adults following vaccination with a twodose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J Med Virol 2011; 83:1885-91.
11. Van Damme P, Kafeja F, Van Der Wielen M, Leyssen M, Jacquet JM. Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age. Pediatr Infect Dis J 2011; 30:703-5.
12. Bian GL, Ma R, Dong HJ, et al. Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children. Vaccine 2010; 28:4798-801.
13. Chan CY, Lee SD, Yu MI, Wang YJ, Chang FY, Lo KJ. Long-term follow-up of hepatitis A vaccination in children. Vaccine 1999; 17:369-72.
14. Fan PC, Chang MH, Lee PI, Safary A, Lee CY. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years. Vaccine 1998; 16:232-5.